Kramer N, Mato U, Krauter S, Buscher N, Afifi A, Herhaus L
Viruses. 2024; 16(9).
PMID: 39339916
PMC: 11436200.
DOI: 10.3390/v16091440.
Penner I, Buscher N, Krauter S, Plachter B
Viruses. 2023; 15(6).
PMID: 37376632
PMC: 10303022.
DOI: 10.3390/v15061333.
Huang S, Pan Y, Zhou Y, Wang X, Mei M, Yang B
J Virol. 2023; 97(5):e0031323.
PMID: 37097169
PMC: 10231247.
DOI: 10.1128/jvi.00313-23.
Turner D, Mathias R
Front Cell Dev Biol. 2022; 10:1053139.
PMID: 36506089
PMC: 9732275.
DOI: 10.3389/fcell.2022.1053139.
Krauter S, Buscher N, Brauchle E, Ortega Iannazzo S, Penner I, Kramer N
Vaccines (Basel). 2022; 10(8).
PMID: 36016214
PMC: 9413975.
DOI: 10.3390/vaccines10081326.
Localization of the WD repeat-containing protein 5 to the Virion Assembly Compartment Facilitates Human Cytomegalovirus Assembly.
Yang B, Yao Y, Wu H, Yang H, Ma X, Li D
J Virol. 2021; 95(8).
PMID: 33504601
PMC: 8103678.
DOI: 10.1128/JVI.02101-20.
Regulation of the MIE Locus During HCMV Latency and Reactivation.
Dooley A, OConnor C
Pathogens. 2020; 9(11).
PMID: 33113934
PMC: 7690695.
DOI: 10.3390/pathogens9110869.
Human cytomegalovirus IE2 drives transcription initiation from a select subset of late infection viral promoters by host RNA polymerase II.
Li M, Ball C, Collins G, Hu Q, Luse D, Price D
PLoS Pathog. 2020; 16(4):e1008402.
PMID: 32251483
PMC: 7162547.
DOI: 10.1371/journal.ppat.1008402.
Production Strategies for Pentamer-Positive Subviral Dense Bodies as a Safe Human Cytomegalovirus Vaccine.
Gogesch P, Penner I, Krauter S, Buscher N, Grode L, Aydin I
Vaccines (Basel). 2019; 7(3).
PMID: 31480520
PMC: 6789746.
DOI: 10.3390/vaccines7030104.
Dense Bodies of a gH/gL/UL128/UL130/UL131 Pentamer-Repaired Towne Strain of Human Cytomegalovirus Induce an Enhanced Neutralizing Antibody Response.
Lehmann C, Falk J, Buscher N, Penner I, Zimmermann C, Gogesch P
J Virol. 2019; 93(17).
PMID: 31189713
PMC: 6694834.
DOI: 10.1128/JVI.00931-19.
Interaction of Human Cytomegalovirus Tegument Proteins ppUL35 and ppUL35A with Sorting Nexin 5 Regulates Glycoprotein B (gpUL55) Localization.
Maschkowitz G, Gartner S, Hofmann-Winkler H, Fickenscher H, Winkler M
J Virol. 2018; 92(9).
PMID: 29444945
PMC: 5899209.
DOI: 10.1128/JVI.00013-18.
Human Cytomegalovirus Nuclear Capsids Associate with the Core Nuclear Egress Complex and the Viral Protein Kinase pUL97.
Milbradt J, Sonntag E, Wagner S, Strojan H, Wangen C, Lenac Rovis T
Viruses. 2018; 10(1).
PMID: 29342872
PMC: 5795448.
DOI: 10.3390/v10010035.
Human cytomegalovirus downregulates SLITRK6 expression through IE2.
Liao H, Sato H, Chiba R, Kawai T, Nakabayashi K, Hata K
J Neurovirol. 2016; 23(1):79-86.
PMID: 27530937
DOI: 10.1007/s13365-016-0475-y.
RhoB is a component of the human cytomegalovirus assembly complex and is required for efficient viral production.
Goulidaki N, Alarifi S, Alkahtani S, Al-Qahtani A, Spandidos D, Stournaras C
Cell Cycle. 2015; 14(17):2748-63.
PMID: 26114383
PMC: 4613856.
DOI: 10.1080/15384101.2015.1066535.
The downregulation of GFI1 by the EZH2-NDY1/KDM2B-JARID2 axis and by human cytomegalovirus (HCMV) associated factors allows the activation of the HCMV major IE promoter and the transition to productive infection.
Sourvinos G, Morou A, Sanidas I, Codruta I, Ezell S, Doxaki C
PLoS Pathog. 2014; 10(5):e1004136.
PMID: 24830456
PMC: 4022736.
DOI: 10.1371/journal.ppat.1004136.
The cellular protein MCM3AP is required for inhibition of cellular DNA synthesis by the IE86 protein of human cytomegalovirus.
Poole E, Bain M, Teague L, Takei Y, Laskey R, Sinclair J
PLoS One. 2012; 7(10):e45686.
PMID: 23094019
PMC: 3477159.
DOI: 10.1371/journal.pone.0045686.
A "coiled-coil" motif is important for oligomerization and DNA binding properties of human cytomegalovirus protein UL77.
Meissner C, Koppen-Rung P, Dittmer A, Lapp S, Bogner E
PLoS One. 2011; 6(10):e25115.
PMID: 21998635
PMC: 3187746.
DOI: 10.1371/journal.pone.0025115.
Human cytomegaloviruses expressing yellow fluorescent fusion proteins--characterization and use in antiviral screening.
Straschewski S, Warmer M, Frascaroli G, Hohenberg H, Mertens T, Winkler M
PLoS One. 2010; 5(2):e9174.
PMID: 20161802
PMC: 2820100.
DOI: 10.1371/journal.pone.0009174.
Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines.
Wang Z, Martinez J, Zhou W, La Rosa C, Srivastava T, Dasgupta A
Vaccine. 2009; 28(6):1547-57.
PMID: 19969118
PMC: 2821965.
DOI: 10.1016/j.vaccine.2009.11.056.
Internal deletions of IE2 86 and loss of the late IE2 60 and IE2 40 proteins encoded by human cytomegalovirus affect the levels of UL84 protein but not the amount of UL84 mRNA or the loading and distribution of the mRNA on polysomes.
Sanders R, Del Rosario C, White E, Spector D
J Virol. 2008; 82(22):11383-97.
PMID: 18787008
PMC: 2573290.
DOI: 10.1128/JVI.01293-08.